Xconomy National

Archives

by in

Entry	Author	Date	Location
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs	Luke Timmerman	05/25/11	Boston
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting	Richard Watson	04/14/11	Seattle
Who’s Going to Pay for Future Drug Development? (Part 1)	Stewart Lyman	03/22/11	National
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders	Gregory T. Huang	03/01/11	Boston
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News	Erin Kutz	01/14/11	Boston
iPierian Nabs $28M, With New Backing From Glaxo and Biogen Idec, To Use Stem Cells for Drug Discovery	Luke Timmerman	09/08/10	San Francisco
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News	Erin Kutz	05/07/10	Boston
Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s	Luke Timmerman	05/03/10	Boston
Quanterix CEO Sets Sight on Early Detection of Cancer, Neurological Diseases in the Blood	Luke Timmerman	01/19/10	Boston
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key	Luke Timmerman	10/18/09	National
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day	Luke Timmerman	10/08/09	Seattle
Avanir’s Results for Neurological Drug Triggers Outburst in Trading	Bruce V. Bigelow	08/11/09	San Diego
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News	Luke Timmerman	05/14/09	Seattle
ProteoTech Raises $519K	Luke Timmerman	05/11/09	Seattle
Acadia Shares Soar on Alliance With Biovail for Parkinson’s Psychosis Drug	Luke Timmerman	05/04/09	San Diego
Biogen Idec Parkinson’s Drug Hits Goal in Pair of Mid-Stage Trials	Luke Timmerman	01/13/09	Boston
Omeros Nabs Michael J. Fox Grant	Luke Timmerman	01/07/09	Seattle
Biogen Idec Takes Aim at New Parkinson’s Paradigm	Luke Timmerman	01/05/09	Boston
Ceregene Drug Fails in Parkinson’s Trial	Luke Timmerman	12/01/08	San Diego
Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes Drugs	Ryan McBride	10/23/08	Boston
Link Medicine Raises $40 Million to Counter Neurodegenerative Disease	Wade Roush	09/30/08	Boston
Proteostasis Eyes Technique to Keep Your Proteins in Balance	Luke Timmerman	09/15/08	Boston
Page 1 of 1